ELIAS Animal Health gets chief revenue officer ahead of canine cancer drug approval

ELIAS Animal Health, a leading companion animal cancer therapeutics company, announced on Wednesday the appointment of Brian Segebrecht as chief revenue officer in anticipation of the impending product approval of the ELIAS Cancer Immunotherapy (ECI) in the fourth quarter of this year. Segebrecht joins the ELIAS leadership team after leading Sentrx Animal Care as chief executive officer until last year. At the company based in Olathe, Kansas, he will lead the commercialization of the company’s...